Cargando…

Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy

BACKGROUND: Biotin-thiamine responsive basal ganglia disease is a severe, but potentially treatable disorder caused by mutations in the SLC19A3 gene. Although the disease is inherited in an autosomal recessive manner, patients with typical phenotypes carrying single heterozygous mutations have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flønes, Irene, Sztromwasser, Paweł, Haugarvoll, Kristoffer, Dölle, Christian, Lykouri, Maria, Schwarzlmüller, Thomas, Jonassen, Inge, Miletic, Hrvoje, Johansson, Stefan, Knappskog, Per M., Bindoff, Laurence A., Tzoulis, Charalampos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749299/ https://www.ncbi.nlm.nih.gov/pubmed/26863430 http://dx.doi.org/10.1371/journal.pone.0149055

Ejemplares similares

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
por: Dölle, Christian, et al.
Publicado: (2016)

Glitazone use associated with reduced risk of Parkinson's disease
por: Brakedal, Brage, et al.
Publicado: (2017)

Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci
por: Gaare, Johannes Jernqvist, et al.
Publicado: (2020)

Psychological Assessment of Patients With Biotin-Thiamine-Responsive Basal Ganglia Disease
por: Alfadhel, Majid, et al.
Publicado: (2017)

Biotin-thiamine-responsive basal ganglia disease: A case report
por: Majumdar, Shamaita, et al.
Publicado: (2021)

An unusually mild case of biotin-thiamine-responsive basal ganglia disease
por: Lail, Gurnoor, et al.
Publicado: (2023)

Early treatment of biotin–thiamine–responsive basal ganglia disease improves the prognosis
por: Wesół-Kucharska, Dorota, et al.
Publicado: (2021)

MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing
por: Haugarvoll, Kristoffer, et al.
Publicado: (2013)

Biotin-Thiamine-Responsive Basal Ganglia Disease in Children: A Treatable Neurometabolic Disorder
por: Saini, Arushi G., et al.
Publicado: (2021)

Whole exome sequencing reveals compound heterozygous mutations in SLC19A3 causing biotin-thiamine responsive basal ganglia disease
por: Sremba, L.J., et al.
Publicado: (2014)

Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease
por: Whitford, Whitney, et al.
Publicado: (2017)

No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
por: Gaare, Johannes J, et al.
Publicado: (2018)

Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition
por: Nido, Gonzalo S., et al.
Publicado: (2020)

Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson’s disease
por: Gaare, Johannes J., et al.
Publicado: (2023)

PNKP Mutations Identified by Whole-Exome Sequencing in a Norwegian Patient with Sporadic Ataxia and Edema
por: Tzoulis, C., et al.
Publicado: (2016)

Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases
por: Alfadhel, Majid, et al.
Publicado: (2013)

3,3′-Diaminobenzidine staining interferes with PCR-based DNA analysis
por: Dölle, Christian, et al.
Publicado: (2018)

Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease
por: Gaare, Johannes J., et al.
Publicado: (2018)

A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population
por: Brakedal, Brage, et al.
Publicado: (2022)

Biotin-Thiamine-Responsive Basal Ganglia Disease: Case Report and Follow-Up of a Patient With Poor Compliance
por: Alabdulqader, Muneera A., et al.
Publicado: (2018)

NSAID use is not associated with Parkinson’s disease incidence: A Norwegian Prescription Database study
por: Brakedal, Brage, et al.
Publicado: (2021)

Mitochondrial Respiratory Chain Dysfunction—A Hallmark Pathology of Idiopathic Parkinson’s Disease?
por: Flønes, Irene H., et al.
Publicado: (2022)

Biotin-thiamine responsive basal ganglia disease in the era of COVID-19 outbreak diagnosis not to be missed: A case report
por: Al-Anezi, Ayed, et al.
Publicado: (2022)

Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain
por: Toker, Lilah, et al.
Publicado: (2021)

A case report of biotin–thiamine-responsive basal ganglia disease in a Saudi child: Is extended genetic family study recommended?
por: Aljabri, Mohammad F., et al.
Publicado: (2016)

Biotin-thiamine responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of cases in Kuwait with novel variants
por: Aburezq, Maryam, et al.
Publicado: (2023)

NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
por: Berven, Haakon, et al.
Publicado: (2023)

GBA2 Mutations Cause a Marinesco-Sjögren-Like Syndrome: Genetic and Biochemical Studies
por: Haugarvoll, Kristoffer, et al.
Publicado: (2017)

Mitochondrial respiratory chain deficiency correlates with the severity of neuropathology in sporadic Creutzfeldt-Jakob disease
por: Flønes, Irene H., et al.
Publicado: (2020)

Novel SACS Mutations Identified by Whole Exome Sequencing in a Norwegian Family with Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
por: Tzoulis, Charalampos, et al.
Publicado: (2013)

Progressive striatal necrosis associated with anti-NMDA receptor antibodies
por: Tzoulis, Charalampos, et al.
Publicado: (2013)

In vitro characterization of six STUB1 variants in spinocerebellar ataxia 16 reveals altered structural properties for the encoded CHIP proteins
por: Pakdaman, Yasaman, et al.
Publicado: (2017)

Molecular Pathogenesis of Polymerase Gamma–Related Neurodegeneration
por: Tzoulis, Charalampos, et al.
Publicado: (2014)

A Japanese patient with neonatal biotin-responsive basal ganglia disease
por: Kobayashi, Mizuki, et al.
Publicado: (2022)

Using urine to diagnose large‐scale mtDNA deletions in adult patients
por: Varhaug, Kristin N., et al.
Publicado: (2020)

Poly-ADP-ribose assisted protein localization resolves that DJ-1, but not LRRK2 or α-synuclein, is localized to the mitochondrial matrix
por: Osuagwu, Nelson, et al.
Publicado: (2019)

Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation
por: Lim, Ryan G., et al.
Publicado: (2022)

Encephalopathy responsive to thiamine in severe COVID-19 patients
por: Branco de Oliveira, Marcus Vinicius, et al.
Publicado: (2021)

Understanding the Epilepsy in POLG Related Disease
por: Hikmat, Omar, et al.
Publicado: (2017)

Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease
por: Flønes, Irene Hana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_009o1tcrp6sq4qs55i77jmfid4